Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov 9;12(11):e062062.
doi: 10.1136/bmjopen-2022-062062.

Efficacy of neuromuscular electrical stimulation with combined low and high frequencies on body composition, peripheral muscle function and exercise tolerance in patients with chronic kidney disease undergoing haemodialysis: a protocol for a randomised, double-blind clinical trial

Igor Gutierrez Moraes  1 , Camila Porto Brito  1 , Davi de Souza Francisco  1 , Larissa Martinez Faria  1 , Claudio Luders  2 , Christina May Moran de Brito  1 , Wellington Pereira Yamaguti  3
Affiliations

Efficacy of neuromuscular electrical stimulation with combined low and high frequencies on body composition, peripheral muscle function and exercise tolerance in patients with chronic kidney disease undergoing haemodialysis: a protocol for a randomised, double-blind clinical trial

Igor Gutierrez Moraes et al. BMJ Open. .

Abstract

Introduction: Neuromuscular electrical stimulation (NMES) as an adjunctive strategy to increase isolated muscular strength or endurance has been widely investigated in patients with chronic kidney disease (CKD) undergoing haemodialysis (HD). However, the efficacy of combined low and high frequencies, to improve both muscular strength and endurance, is unknown. This trial aims to evaluate the efficacy of this combined NMES strategy in this population.

Methods and analysis: This is a randomised controlled trial with blinded assessments and analysis. A total of 56 patients with CKD undergoing HD will be recruited and randomised to an NMES protocol. The evaluations will be performed on three different days at baseline and after 24 sessions of follow-up. Assessments will include the background, insulin-like growth factor, lactate measurement, malnutrition and inflammation score evaluation, an electrical bioimpedance examination, global muscular evaluation by means of the Medical Research Council scale, handgrip strength evaluation, muscular isokinetic evaluation of lower limbs, 6 min step test performance and quality of life (QoL) questionnaire with emphasis on physical function. The patients will be allocated in one of the following four groups: 1) combined low and high frequencies; 2) low frequency; 3) high frequency; and 4) sham stimulation with minimal intensity to generate only sensory perception (with no visible contraction). In all groups, the intensity throughout the session will be the highest tolerated by patient (except for control group). The primary endpoint is the change of peripheral muscle function (muscular strength and endurance). The secondary endpoints will be the changes of body composition; muscle trophism; exercise tolerance; QoL; and nutritional, inflammatory, and metabolic markers. The findings of this study are expected to provide valuable knowledge on how to optimise the NMES intervention, with improvements in both muscle strength and endurance.

Ethics and dissemination: This protocol has been approved by the Ethics Committee on Research with Humans of Hospital Sírio-Libanês (approval no. 24337707). Written informed consent will be obtained from each participant. The results of the study will be published in peer-reviewed journals.

Trial registration number: NCT03779126.

Keywords: Chronic renal failure; Dialysis; Nephrology; REHABILITATION MEDICINE.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Flow diagram of the progress through the phases of a parallel randomised trial of two groups (ie, enrolment, intervention allocation, follow-up and data analysis). Intervention 1, combined frequency; intervention 2, high frequency; and intervention 3, low frequency.
Figure 2
Figure 2
Neuromuscular electrical stimulation of low and high frequencies.
Figure 3
Figure 3
Electrical bioimpedance.
Figure 4
Figure 4
Hand grip strength and isokinetic dynamometry.
Figure 5
Figure 5
Exercise tolerance.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Di Lullo L, House A, Gorini A, et al. . Chronic kidney disease and cardiovascular complications. Heart Fail Rev 2015;20:259–72. 10.1007/s10741-014-9460-9 - DOI - PubMed
    1. Schardong J, Marcolino MAZ, Plentz RDM. Muscle atrophy in chronic kidney disease. Adv Exp Med Biol 2018;1088:393–412. 10.1007/978-981-13-1435-3_18 - DOI - PubMed
    1. Kooman JP, Dekker MJ, Usvyat LA, et al. . Inflammation and premature aging in advanced chronic kidney disease. Am J Physiol Renal Physiol 2017;313:F938–50. 10.1152/ajprenal.00256.2017 - DOI - PubMed
    1. Musso CG, Jauregui JR, Macías Núñez JF. Frailty phenotype and chronic kidney disease: a review of the literature. Int Urol Nephrol 2015;47:1801–7. 10.1007/s11255-015-1112-z - DOI - PubMed
    1. Roshanravan B, Gamboa J, Wilund K. Exercise and CKD: skeletal muscle dysfunction and practical application of exercise to prevent and treat physical impairments in CKD. Am J Kidney Dis 2017;69:837–52. 10.1053/j.ajkd.2017.01.051 - DOI - PMC - PubMed

Publication types

Associated data